Who Owns Cytek Biosciences Stock?
NASDAQ: CTKBIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 63.67%
- Held by insiders
- 8.68%
- Institutional holders
- 209
- Institutions 63.7%
- Insiders 8.7%
- Public and other 27.6%
Who owns Cytek Biosciences stock?
Institutional investors own about 63.7% of Cytek Biosciences's shares, spread across 209 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 8.68% of CTKB.
The largest institutional holders are Blackrock Inc. (9.32%), Millennium Management Llc (7.14%) and HHLR Advisors, LTD (5.09%). Together, the top 10 institutions control 43.4% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their CTKB positions and 5 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of CTKB
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 12.19M | 9.32% | +27.2% |
| Millennium Management Llc | 9.34M | 7.14% | +48.4% |
| HHLR Advisors, LTD | 6.66M | 5.09% | 0.0% |
| Boston Partners | 6.53M | 4.99% | -14.8% |
| Topline Capital Management, LLC | 6.28M | 4.80% | -11.1% |
| Vanguard Capital Management LLC | 4.89M | 3.74% | -1.1% |
| Geode Capital Management, LLC | 3.07M | 2.34% | +0.2% |
| Acadian Asset Management. LLC | 2.72M | 2.08% | +97.6% |
| Dimensional Fund Advisors LP | 2.57M | 1.96% | -1.9% |
| State Street Corporation | 2.55M | 1.95% | -0.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of CTKB
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.53M | 2.70% |
| iShares Trust-iShares Russell 2000 ETF | 3.18M | 2.43% |
| Trust for Professional Managers-Column Small Cap Select Fund | 2.58M | 1.98% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.35M | 1.03% |
| ROYCE MICRO-CAP TRUST, INC.-Royce Micro-Cap Trust Inc | 1.32M | 1.01% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.30M | 0.99% |
| iShares Trust-iShares Russell 2000 Value ETF | 1.15M | 0.88% |
| RBB Fund, Inc.-WPG Partners Select Small Cap Value Fund | 1.12M | 0.86% |
| iShares Trust-iShares Biotechnology ETF | 944.42K | 0.72% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 696.71K | 0.53% |
Frequently asked questions
Who is the largest shareholder of Cytek Biosciences?
Blackrock Inc. is the largest institutional shareholder of CTKB, owning 9.32% of shares outstanding (12.19M shares) as of its latest 13F filing.
What percentage of Cytek Biosciences is owned by institutions?
Institutions own about 63.7% of CTKB shares and 69.7% of the public float.
How much of Cytek Biosciences do insiders own?
Insiders, such as officers and directors, own about 8.68% of CTKB shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.